Omnicell (OMCL)
(Delayed Data from NSDQ)
$29.76 USD
-1.25 (-4.03%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $29.76 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OMCL 29.76 -1.25(-4.03%)
Will OMCL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OMCL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OMCL
Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates
OMCL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?
OMCL vs. DOCS: Which Stock Is the Better Value Option?
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy?
Other News for OMCL
Omnicell, Inc. 2025 Q2 - Results - Earnings Call Presentation
Omnicell, Inc. (OMCL) Q2 2025 Earnings Conference Call Transcript
Q2 2025 Omnicell Inc Earnings Call Transcript
Omnicell Q2 Earnings: Market Ignoring The Segments
OMCL Increases 2025 Revenue Forecast